Aymeric Seron
Overview
Explore the profile of Aymeric Seron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fretellier N, Rasschaert M, Bocanegra J, Robert P, Factor C, Seron A, et al.
Invest Radiol
. 2021 Jun;
56(12):826-836.
PMID: 34091462
Objective: The aim of this study was to investigate the toxicological profile of gadopiclenol, a new high-relaxivity macrocyclic gadolinium-based contrast agent (GBCA), in renally impaired rats, in comparison with 2...
2.
Sherman W, Bartunek J, Dolatabadi D, Sanz-Ruiz R, Beleslin B, Wojakowski W, et al.
JACC Cardiovasc Interv
. 2018 Feb;
11(4):412-414.
PMID: 29471956
No abstract available.
3.
Teerlink J, Metra M, Filippatos G, Davison B, Bartunek J, Terzic A, et al.
Eur J Heart Fail
. 2017 Jun;
19(11):1520-1529.
PMID: 28560782
Aims: Left ventricular (LV) reverse remodelling is an important marker of improved outcomes in patients with advanced heart failure (HF). We examined the impact of the intramyocardial administration of bone-marrow-derived,...
4.
Bartunek J, Terzic A, Davison B, Filippatos G, Radovanovic S, Beleslin B, et al.
Eur Heart J
. 2016 Dec;
38(9):648-660.
PMID: 28025189
Aims: Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy...
5.
Dalen M, Behfar A, Terzic A, Schiller P, Seron A, Sherman W, et al.
J Cardiovasc Transl Res
. 2015 Jul;
8(6):381-4.
PMID: 26149227
Endomyocardial delivery in the setting of active left ventricular assist device (LVAD) support has rarely been studied. The objective was to establish a protocol for endomyocardial injections during LVAD support...
6.
Behfar A, Latere J, Bartunek J, Homsy C, Daro D, Crespo-Diaz R, et al.
Circ Cardiovasc Interv
. 2013 Dec;
6(6):710-8.
PMID: 24326777
Background: Regenerative cell-based therapies are associated with limited myocardial retention of delivered stem cells. The objective of this study is to develop an endocardial delivery system for enhanced cell retention....
7.
Vergnol G, Renard E, Haroun F, Guerin P, Seron A, Bureau C, et al.
J Mater Sci Mater Med
. 2013 Aug;
24(12):2729-39.
PMID: 23904056
Drug-eluting stents have been developed to reduce the risk of restenosis after angioplasty. To facilitate the adhesion of a poly(lactic acid) (PLA) overlayer loaded with rapamycin (20 wt%), a biodegradable...
8.
Seron A, Moine L, Laurent A, Wassef M, Guiffant G, Flaud P, et al.
Biomaterials
. 2009 Apr;
30(20):3436-43.
PMID: 19345409
We report the preparation of an embolic agent based on specific association of an acrylic copolymer with dedicated particles formulated in ethanol. The copolymers were synthesized by radical polymerization of...
9.
Laurent A, Wassef M, Saint Maurice J, Namur J, Pelage J, Seron A, et al.
Invest Radiol
. 2005 Dec;
41(1):8-14.
PMID: 16355034
Objective: The objective of this study was to compare the repartition in the renal arterial vasculature of tris-acryl gelatin microspheres (TGMS) and polyvinyl alcohol microspheres (PVAMS) of 3 calibers (500-700,...